Back to search

France· FR:65771499

ADRIBLASTINE 10 mg, poudre pour solution injectable en flacon

A medicinal product, registered in France by PFIZER HOLDING FRANCE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedADRIBLASTINE 10 mg, poudre pour solut…ATC—REGISTER NO.FR:65771499PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
PFIZER HOLDING FRANCE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400933408022
    1 flacon(s) en verre
    EUR 13.67

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ADRIBLASTINE in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ADRIBLASTINE products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Adriblastin, Doxorubicin Accord
  • Belgium · Adriblastina Ready To Use, Doxorubicin Accord Healthcare
  • Bulgaria · Доксорубицин Акорд
  • Cyprus · Adriblastina
  • Czechia · Doxorubicin Ebewe, Doxorubicin Medac
  • Germany · Adriacept Blasen-Instillations-Set, Adrimedac
  • Denmark · Adriamycin, Doxorubicin Accord
  • Estonia · Doxorubicin Accord
  • Spain · Doxorubicina Accord, Doxorubicina Aurovitas
  • Finland · Doxorubicin Accord, Doxorubicin Medac
  • United Kingdom (Northern Ireland) · Doxorubicin Accord Healthcare, Doxorubicin Hydrochloride Medac
  • Greece · Adriblastina, Doxiprol
  • Croatia · Doxorubicin Pliva, Sindroxocin
  • Hungary · Doxorubicin Accord, Doxorubicin Sandoz
  • Ireland · Doxorubicin Accord Healthcare Ireland, Doxorubicin Rivopharm
  • Iceland · Caelyx Pegylated Liposomal, Doxorubicin Medac
  • Italy · Adriblastina, Doxorubicin Teva
  • Liechtenstein · Caelyx Pegylated Liposomal, Myocet Liposomal
  • Lithuania · Doxorubicin Accord, Doxorubicin Ebewe
  • Luxembourg · Adriblastina Ready To Use, Doxorubicine Teva
  • Latvia · Doxorubicin Accord
  • Malta · Doxorubicin Accord Healthcare
  • Netherlands · Doxorubicin Hydrochloride Eugia, Doxorubicine Accord
  • Norway · Adriamycin, Caelyx Pegylated Liposomal
  • Poland · Doxorubicin Ebewe, Doxorubicinum Accord
  • Portugal · Doxorrubicina Accord, Doxorrubicina Aurovitas
  • Romania · Doxlox, Doxorubicină Accord
  • Sweden · Doxorubicin Accord, Doxorubicin Ebewe
  • Slovenia · Doksorubicin Accord, Doksorubicin Sandoz
  • Slovakia · Doxorubicin Medac, Doxorubicin Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7ad604d-ab4c-446c-a417-5ffb4e04c5bc
GET /v1/drugs/c7ad604d-ab4c-446c-a417-5ffb4e04c5bc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65771499",
  "date_amm": "1991-07-31",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre pour solution injectable",
  "voies_administration": "intraveineuse;intravésicale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ADRIBLASTINE.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.